QCBGX
Price
$21.52
Change
-$0.02 (-0.09%)
Updated
Jun 5 closing price
Net Assets
268.34M
RLBFX
Price
$35.83
Change
-$0.04 (-0.11%)
Updated
Jun 5 closing price
Net Assets
243.73B
Interact to see
Advertisement

QCBGX vs RLBFX

Header iconQCBGX vs RLBFX Comparison
Open Charts QCBGX vs RLBFXBanner chart's image
Federated Hermes MDT Balanced C
Price$21.52
Change-$0.02 (-0.09%)
VolumeN/A
Net Assets268.34M
American Funds American Balanced R5
Price$35.83
Change-$0.04 (-0.11%)
VolumeN/A
Net Assets243.73B
QCBGX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QCBGX vs. RLBFX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCBGX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 244B vs. QCBGX (268M). RLBFX pays higher dividends than QCBGX: RLBFX (2.18) vs QCBGX (0.65). QCBGX was incepted earlier than RLBFX: QCBGX (20 years) vs RLBFX (23 years). QCBGX (2.12) is less costly to investors than RLBFX (0.29). QCBGX is a more actively managed with annual turnover of: 68.00 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than QCBGX: RLBFX (250) vs QCBGX (1500). RLBFX annual gain was more profitable for investors over the last year : 7.28 vs. QCBGX (1.47). RLBFX return over 5 years is better than : 36.31 vs. QCBGX (16.56).
QCBGXRLBFXQCBGX / RLBFX
Total Expense Ratio2.120.29731%
Annual Report Gross Expense Ratio2.120.29731%
Fund Existence20 years23 years-
Gain YTD4.0084.70285%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets268M244B0%
Annual Yield % from dividends0.652.1830%
Returns for 1 year1.477.2820%
Returns for 3 years12.8223.8854%
Returns for 5 years16.5636.3146%
Returns for 10 years35.3661.8957%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPO116.671.74
+1.51%
XPO
FHB23.610.02
+0.08%
First Hawaiian
LCTX0.66N/A
-0.18%
Lineage Cell Therapeutics
EZGO0.36N/A
-1.30%
EZGO Technologies Ltd
RYI21.43-0.48
-2.20%
RYERSON HOLDING Corp